U. Koivisto

发表

EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring

H. Heidbuchel, R. Peinado, L. Annemans, 2014, European heart journal.

Familial hypercholesterolaemia in Finland: common, rare and mild mutations of the LDL receptor and their clinical consequences

P. Kovanen, H. Gylling, T. Miettinen, 2001, Annals of medicine.

A Novel Cellular Phenotype for Familial Hypercholesterolemia due to a Defect in Polarized Targeting of LDL Receptor

I. Mellman, A. Hubbard, U. Koivisto, 2001, Cell.

The use of PCR in diagnosing lipoprotein disorders.

K. Kontula, U. Koivisto, H. Miettinen, 1992, Annals of medicine.

Molecular genetics of familial hypercholesterolaemia: common and rare mutations of the low density lipoprotein receptor gene.

K. Kontula, U. Koivisto, H. Turtola, 1992, Annals of medicine.

Prevalence of familial hypercholesterolemia among young north Karelian patients with coronary heart disease: a study based on diagnosis by polymerase chain reaction.

M. Taskinen, K. Kontula, U. Koivisto, 1993, Journal of Lipid Research.

Predictors of pocket hematoma in patients on antithrombotic therapy undergoing cardiac rhythm device implantation: insights from the FinPAC trial

P. Karjalainen, W. Nammas, J. Koistinen, 2014, Annals of medicine.

Polymorphisms of the genes encoding apoproteins A-I, B, C-III, and E and LDL receptor, and cholesterol and LDL metabolism during increased cholesterol intake. Common alleles of the apoprotein E gene show the greatest regulatory impact.

H. Gylling, T. Miettinen, K. Kontula, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Stimulation of Na+/H+ exchange by insulin and phorbol ester during differentiation of 3T3-L1 cells. Relation to hexose uptake.

A. Klip, T. Ramlal, U. Koivisto, 1988, Endocrinology.

17 Remote Monitoring of Implantable Cardioverter-Defibrillator Therapy

U. Koivisto, M. P. Raatikainen, 2012 .

Glucose transport activity in L6 muscle cells is regulated by the coordinate control of subcellular glucose transporter distribution, biosynthesis, and mRNA transcription.

A. Klip, J. Pessin, P. Bilan, 1990, The Journal of biological chemistry.

Deletion of exon 15 of the LDL receptor gene is associated with a mild form of familial hypercholesterolemia. FH-Espoo.

P. Kovanen, H. Gylling, T. Miettinen, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Diagnosis of heterozygous familial hypercholesterolemia. DNA analysis complements clinical examination and analysis of serum lipid levels.

T. Miettinen, K. Kontula, U. Koivisto, 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

Prevalence and geographical distribution of major LDL receptor gene rearrangements in Finland

J. Viikari, T. Ebeling, M. Savolainen, 1992, Journal of internal medicine.

Differential regulation of the GLUT-1 and GLUT-4 glucose transport systems by glucose and insulin in L6 muscle cells in culture.

A. Klip, P. Bilan, T. Ramlal, 1991, The Journal of biological chemistry.

Molecular characterization of minor gene rearrangements in Finnish patients with heterozygous familial hypercholesterolemia: identification of two common missense mutations (Gly823-->Asp and Leu380-->His) and eight rare mutations of the LDL receptor gene.

J. Viikari, K. Kontula, U. Koivisto, 1995, American journal of human genetics.

The Rab8 GTPase selectively regulates AP-1B–dependent basolateral transport in polarized Madin-Darby canine kidney cells

I. Mellman, M. Pypaert, U. Koivisto, 2003, The Journal of cell biology.

A novel deletion/inversion mutation in the low‐density lipoprotein receptor gene as a cause of heterozygous familial hypercholesterolemia

K. Kontula, U. Koivisto, 1996, Human mutation.

Familial Hypercholes terolemia

K. Kontula, U. Koivisto, 1996 .

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Laminin and its neurite outgrowth‐promoting domain in the brain in Alzheimer's disease and Down's syndrome patients

J. Risteli, U. Koivisto, L. Risteli, 1992, Journal of neuroscience research.

Familial moderate hypercholesterolemia caused by Asp235-->Glu mutation of the LDL receptor gene and co-occurrence of a de novo deletion of the LDL receptor gene in the same family.

K Kontula, H. Gylling, T. Miettinen, 1997, Arteriosclerosis, thrombosis, and vascular biology.

The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland.

K Kontula, A. Syvänen, R. Frants, 1992, The Journal of clinical investigation.

Remote Monitoring of Implantable Cardioverter-Defibrillator Therapy

M. J. Pekka Raatikainen, Ulla-Maija Koivisto, U. Koivisto, 2011 .

A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia.

O. Jänne, K. Kontula, J. Palvimo, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment--the FinPAC study.

P. Karjalainen, J. Koistinen, V. Virtanen, 2013, International journal of cardiology.